Houston, TXNCT04751396Now EnrollingIRB Ready

Ankylosing Spondylitis Clinical Trial in Houston, TX

Access cutting-edge ankylosing spondylitis treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access ankylosing spondylitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ankylosing spondylitis treatment provided free

Apply for This Houston Location

Check if you qualify for this ankylosing spondylitis clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Ankylosing Spondylitis Study in Houston

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of the tool. Researchers will use the information collected to improve the educational materials that will help patients make future decisions about their treatment.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Diagnosis of melanoma
Diagnosis of pre-existing autoimmune disease
Inflammatory bowel disease
Diagnosis of Crohn's disease or ulcerative colitis by a gastroenterologist
For ulcerative colitis, proof of chronic changes over time (i.e., 6 months) and signs of inflammation histologically
Treatment with aminosalicylates, corticosteroids, thiopurines, or immune modifiers (e.g., calcineurin inhibitors, methotrexate, adhesion molecule antagonists)
Rheumatoid arthritis
Diagnosis of rheumatoid arthritis by a rheumatologist
Treatment with traditional disease-modifying antirheumatic drugs (e.g., methotrexate, sulfasalazine, hydroxychloroquine) or targeted therapy
Systemic lupus erythematosus
Diagnosis of systemic lupus erythematosus by a rheumatologist
Diagnosis of psoriasis by a dermatologist
Treatment with corticosteroids, vitamin D analogs, anthralin, topical retinoids, calcineurin inhibitors, salicylic acid, coal tar, or moisturizers; light therapy, including sunlight, ultraviolet B (UVB) phototherapy, narrowband UVB therapy, Goeckerman therapy, photochemotherapy, excimer laser, or pulsed dye laser; or systemic medications, including retinoids, methotrexate, cyclosporine, hydroxyurea, or thioguanine or targeted therapies
Spondyloarthropathies
Diagnosis of ankylosing spondylitis, reactive arthritis, psoriatic arthritis, or enteropathic arthritis/spondylitis by a rheumatologist
Treatment with disease-modifying antirheumatic drugs (e.g., sulfasalazine) or targeted therapy
Age of 18 years or older
Patients whose physicians had recommended they begin using any of the currently available immune checkpoint inhibitors or people who are in the midst of or have already made the decision on whether or not start an immune checkpoint inhibitor
E-mail access and computer with Internet access or telephone
Ability to communicate in English or Spanish
Prescribed immune checkpoint inhibitors
Are providing care for patients with melanoma
In the clinics at MD Anderson

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT04751396) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ankylosing Spondylitis Treatment Options in Houston, TX

If you're searching for ankylosing spondylitis treatment options in Houston, TX, this clinical trial (NCT04751396) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ankylosing spondylitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ankylosing spondylitis clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Houston, TX

See all ankylosing spondylitis clinical trials recruiting in Houston — not just this study.

Browse Ankylosing Spondylitis Trials in Houston

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX